The interaction between H2-receptor antagonists and beta-adrenoceptor blockers

Area of Science:

• Pharmacology
• Drug Interactions
• Clinical Pharmacology

Background:

• H2-receptor antagonists like cimetidine and ranitidine are commonly used.
• Beta-adrenoceptor blockers are widely prescribed for cardiovascular conditions.
• Potential drug interactions between these classes require investigation.

Purpose of the Study:

• To investigate the pharmacokinetic and pharmacodynamic interactions between cimetidine/ranitidine and several beta-blockers.
• To determine the impact of H2-receptor antagonist co-administration on beta-blocker plasma levels and effects.

Main Methods:

• Healthy volunteers received 7 days of monotherapy with specific beta-blockers (penbutolol, propranolol, metoprolol, pindolol, atenolol).
• Co-administration with cimetidine or ranitidine was performed.
• Plasma levels of beta-blockers and their metabolites were measured.
• Pharmacodynamic effects, such as inhibition of exercise-induced tachycardia, were assessed.

Main Results:

• Cimetidine significantly increased plasma levels of propranolol and metoprolol.
• Cimetidine had minor effects on pindolol and no effect on atenolol pharmacokinetics.
• Ranitidine slightly increased metoprolol peak plasma concentration but did not affect atenolol.
• No significant impact on the pharmacodynamic effects (inhibition of tachycardia) of beta-blockers was observed with cimetidine.

Conclusions:

• Cimetidine exhibits significant drug interactions with certain beta-blockers, particularly those metabolized via the cytochrome P-450 pathway.
• Ranitidine shows a less pronounced interaction profile compared to cimetidine.
• These findings highlight the importance of considering potential interactions when co-prescribing H2-receptor antagonists and beta-blockers.